Related Experiment Video
Updated: Aug 7, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Sleep dysfunction in Parkinson's disease
1Ludwig Maximilian University, Munich, Germany.
Clinical Neuroscience (New York, N.Y.)
|April 29, 2000
Summary
Sleep disturbances are common in Parkinson's disease (PD), affecting 60-90% of patients. Management requires assessing sleep history, motor symptoms, and psychiatric status for tailored treatments.
Area of Science:
- Neurology
- Sleep Medicine
- Movement Disorders
Background:
- Sleep complaints affect 60-90% of Parkinson's disease (PD) patients.
- Sleep disturbances stem from disease-related mechanisms, secondary factors, and dopaminergic treatment.
- Common issues include fragmented sleep, nocturnal immobility, tremor, dyskinesias, and restless legs syndrome.
Purpose of the Study:
- To review the spectrum of sleep disturbances in Parkinson's disease.
- To highlight the contribution of PD and its treatment to sleep problems.
- To outline diagnostic and therapeutic strategies for sleep disorders in PD.
Main Methods:
- Review of literature on sleep disturbances in Parkinson's disease.
- Analysis of disease-related and treatment-induced sleep phenomena.
- Discussion of diagnostic approaches including sleep history and polysomnography.
- Outline of therapeutic interventions for sleep disorders in PD.
Main Results:
- Parkinson's disease is associated with fragmented sleep, motor phenomena (tremor, dyskinesias), restless legs syndrome, and respiratory dysfunction.
- REM sleep behavior disorder (RBD) with nightmares is more frequent in PD and can be a preclinical symptom.
- Depression, hallucinations, and psychosis further complicate sleep in PD patients.
Conclusions:
- Comprehensive assessment of sleep, motor, and psychiatric status is crucial for managing PD-related sleep disturbances.
- Treatment strategies should be individualized, adjusting dopaminergic therapy and other medications.
- Specific treatments include benzodiazepines for RBD and clozapine for psychosis.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...